• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗后乳腺 MRI 成像和 PET/CT 对浸润性导管癌患者腋窝淋巴结转移(ypN2-3)的预测。

Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.

机构信息

Department of Radiology, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.

Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

出版信息

Sci Rep. 2018 Feb 16;8(1):3181. doi: 10.1038/s41598-018-21554-z.

DOI:10.1038/s41598-018-21554-z
PMID:29453385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5816592/
Abstract

We aimed to investigate the value of breast magnetic resonance (MR) imaging and positron emission tomography-computed tomography (PET/CT) in predicting advanced axillary lymph node (ALN) metastases (ypN2-3) after neoadjuvant chemotherapy (NAC) in invasive ductal carcinoma patients. A total of 108 patients with invasive ductal carcinoma underwent breast MR imaging and PET/CT both before and after NAC (termed initial staging and restaging, respectively). The number of positive ALNs and the short diameter (SD) of the largest ALN on breast MR imaging and maximal standardized uptake value (SUVmax) in the ALNs on PET/CT were evaluated. Odds ratio (OR) for prediction of advanced ALN metastases was calculated. The negative predictive value (NPV) of restaging imaging for exclusion of advanced ALN metastases was also calculated. Patients with advanced ALN metastases were more likely to have a higher number (≥2) of positive LNs (OR, 8.06; P = 0.015) on restaging MR imaging. No clinico-pathological factors were significantly associated with advanced ALN metastases. With restaging MR imaging, PET/CT, and MR imaging plus PET/CT, the NPV for excluding advanced ALN metastases was 97.3%, 94.4%, and 100.0%. A higher number of positive ALNs on restaging MR imaging was an independent predictor for advanced ALN metastases after NAC.

摘要

我们旨在探讨乳腺磁共振(MR)成像和正电子发射断层扫描-计算机断层扫描(PET/CT)在预测新辅助化疗(NAC)后浸润性导管癌患者腋窝淋巴结(ALN)转移(ypN2-3)中的价值。共有 108 例浸润性导管癌患者分别在 NAC 前(初始分期)和后(重新分期)进行了乳腺 MR 成像和 PET/CT 检查。评估了乳腺 MR 成像上阳性 ALN 的数量和最大 ALN 的短直径(SD)以及 PET/CT 上 ALN 的最大标准化摄取值(SUVmax)。计算了预测高级 ALN 转移的优势比(OR)。还计算了重新分期成像排除高级 ALN 转移的阴性预测值(NPV)。具有高级 ALN 转移的患者更有可能在重新分期的 MR 成像上具有更多的阳性 LNs(OR,8.06;P=0.015)。没有临床病理因素与高级 ALN 转移明显相关。对于重新分期的 MR 成像、PET/CT 和 MR 成像加 PET/CT,排除高级 ALN 转移的 NPV 分别为 97.3%、94.4%和 100.0%。重新分期的 MR 成像上阳性 ALN 数量较多是 NAC 后高级 ALN 转移的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255c/5816592/53e6e0fb9b34/41598_2018_21554_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255c/5816592/53e6e0fb9b34/41598_2018_21554_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/255c/5816592/53e6e0fb9b34/41598_2018_21554_Fig1_HTML.jpg

相似文献

1
Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.新辅助化疗后乳腺 MRI 成像和 PET/CT 对浸润性导管癌患者腋窝淋巴结转移(ypN2-3)的预测。
Sci Rep. 2018 Feb 16;8(1):3181. doi: 10.1038/s41598-018-21554-z.
2
Predictive Value of F-FDG PET/CT for Axillary Lymph Node Metastasis in Invasive Ductal Breast Cancer.F-FDG PET/CT对浸润性导管癌腋窝淋巴结转移的预测价值
Ann Surg Oncol. 2017 Aug;24(8):2174-2181. doi: 10.1245/s10434-017-5860-0. Epub 2017 Apr 21.
3
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.18F-FDG PET/CT 预测新辅助化疗后腋窝病理淋巴结转移的价值
Breast Cancer. 2013 Apr;20(2):167-73. doi: 10.1007/s12282-011-0323-0. Epub 2012 Feb 7.
4
Factors affecting the accuracy of F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer.影响F-FDG PET/CT评估浸润性乳腺癌腋窝转移准确性的因素。
Niger J Clin Pract. 2019 Jan;22(1):63-68. doi: 10.4103/njcp.njcp_198_18.
5
Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic performance.[18F]氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描、超声检查和超声引导下细针穿刺活检在乳腺癌患者腋窝淋巴结诊断中的作用:诊断性能比较。
J Ultrasound Med. 2014 Jun;33(6):1013-21. doi: 10.7863/ultra.33.6.1013.
6
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描联合超声引导下细针穿刺细胞学检查对乳腺癌患者腋窝淋巴结状态的诊断性能。
Eur J Surg Oncol. 2013 Jan;39(1):26-30. doi: 10.1016/j.ejso.2012.10.012. Epub 2012 Nov 2.
7
18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.新辅助治疗两个周期后的18F-氟脱氧葡萄糖(FDG)PET/CT可预测HER2阴性乳腺癌的反应,但对HER2阳性乳腺癌无效。
Oncotarget. 2015 Oct 6;6(30):29388-95. doi: 10.18632/oncotarget.5001.
8
The prognostic value of SUV measuring on primary lesion and ALN by F-FDG PET or PET/CT in patients with breast cancer.F-FDG PET 或 PET/CT 检测原发灶和腋窝淋巴结 SUV 对乳腺癌患者的预后价值。
Eur J Radiol. 2018 Aug;105:1-7. doi: 10.1016/j.ejrad.2018.05.014. Epub 2018 May 17.
9
Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohistochemistry and inflammatory markers.(18F)FDG PET/CT对浸润性导管癌患者原发肿块和腋窝淋巴结转移的代谢及基于体积的参数:与分子亚型、腋窝淋巴结转移、免疫组化及炎症标志物相关的回顾性分析
Nucl Med Commun. 2019 Oct;40(10):1051-1059. doi: 10.1097/MNM.0000000000001074.
10
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)与腋窝超声对乳腺癌患者淋巴结转移检测的诊断价值比较。
Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

引用本文的文献

1
Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response.正电子发射断层扫描的创新与乳腺癌治疗反应评估的最新技术水平
J Clin Med. 2023 Dec 27;13(1):154. doi: 10.3390/jcm13010154.
2
A multivariable model of ultrasound and clinicopathological features for predicting axillary nodal burden of breast cancer: potential to prevent unnecessary axillary lymph node dissection.用于预测乳腺癌腋窝淋巴结负担的超声和临床病理特征的多变量模型:有潜力预防不必要的腋窝淋巴结清扫术。
BMC Cancer. 2023 Dec 21;23(1):1264. doi: 10.1186/s12885-023-11751-z.
3
Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients.

本文引用的文献

1
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial.使用超声和触诊预测新辅助化疗后腋窝淋巴结状态——多中心SENTINA试验结果
Breast. 2017 Feb;31:202-207. doi: 10.1016/j.breast.2016.11.012. Epub 2016 Nov 24.
2
Accuracy of axillary ultrasound after different neoadjuvant chemotherapy cycles in breast cancer patients.乳腺癌患者不同新辅助化疗周期后腋窝超声检查的准确性
Oncotarget. 2017 May 30;8(22):36696-36706. doi: 10.18632/oncotarget.13313.
3
Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
超声、磁共振成像及F-18氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在乳腺癌患者新辅助化疗后检测腋窝淋巴结转移中的效能
Diagnostics (Basel). 2021 Dec 14;11(12):2361. doi: 10.3390/diagnostics11122361.
4
Preoperative axillary nodal staging with ultrasound and magnetic resonance imaging: predictive values of quantitative and semantic features.术前超声和磁共振成像对腋窝淋巴结的分期:定量和语义特征的预测价值。
Br J Radiol. 2018 Dec;91(1092):20180507. doi: 10.1259/bjr.20180507. Epub 2018 Aug 29.
在新诊断的乳腺癌患者中,将标准乳腺磁共振成像(MRI)与腋窝超声的常规使用进行比较,以区分腋窝淋巴结疾病为无、局限或进展期。
Eur J Radiol. 2016 Dec;85(12):2288-2294. doi: 10.1016/j.ejrad.2016.10.030. Epub 2016 Oct 28.
4
A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.乳腺癌患者腋窝淋巴结转移病理反应预测的列线图。
Sci Rep. 2016 Aug 31;6:32585. doi: 10.1038/srep32585.
5
Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease?乳腺癌患者术前通过乳腺磁共振成像(MRI)评估腋窝淋巴结:乳腺MRI能否排除晚期淋巴结疾病?
Eur Radiol. 2016 Nov;26(11):3865-3873. doi: 10.1007/s00330-016-4235-4. Epub 2016 Feb 2.
6
¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.¹⁸F-FDG PET/CT用于监测乳腺癌的治疗反应
J Nucl Med. 2016 Feb;57 Suppl 1(Suppl 1):34S-9S. doi: 10.2967/jnumed.115.157875.
7
Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.用于预测经细胞学证实的淋巴结阳性乳腺癌新辅助化疗后腋窝病理完全缓解的预后列线图
Medicine (Baltimore). 2015 Oct;94(43):e1720. doi: 10.1097/MD.0000000000001720.
8
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and ¹⁸F-FDG PET/CT.乳腺癌患者新辅助化疗后淋巴结状态的评估:超声、MRI和¹⁸F-FDG PET/CT诊断性能的比较
Br J Radiol. 2015 Aug;88(1052):20150143. doi: 10.1259/bjr.20150143.
9
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).新辅助化疗后的腋窝超声及其对前哨淋巴结手术的影响:美国外科医师学会肿瘤学组Z1071试验(联盟)的结果
J Clin Oncol. 2015 Oct 20;33(30):3386-93. doi: 10.1200/JCO.2014.57.8401. Epub 2015 Feb 2.
10
Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.¹⁸F-FDG 全身PET-MRI同步成像在乳腺癌初始分期中的应用:一项初步研究
Eur J Radiol. 2014 Dec;83(12):2231-2239. doi: 10.1016/j.ejrad.2014.09.008. Epub 2014 Sep 28.